INmune Bio, Inc. (INMB)

NASDAQ: INMB · Real-Time Price · USD

7.63

+0.79 (11.55%)

At close: Apr 9, 2025, 4:00 PM

7.11

-0.52 (-6.82%)

Pre-market: Apr 10, 2025, 6:01 AM EDT

INmune Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 9, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	175	104	203	114	182	232	Upgrade
Market Cap Growth	-48.97%	-48.97%	78.35%	-37.48%	-21.41%	270.69%	Upgrade
Enterprise Value	154	73	175	72	112	207	Upgrade
Last Close Price	7.63	4.67	11.26	6.34	10.20	17.22	Upgrade
PS Ratio	12497.02	7396.10	1309.19	304.22	1005.53	21052.15	Upgrade
PB Ratio	5.30	3.23	5.32	1.89	2.27	5.98	Upgrade
P/TBV Ratio	11.23	6.65	9.74	2.61	2.86	10.41	Upgrade
EV/Sales Ratio	11030.02	5207.60	1127.89	191.85	619.14	18856.25	Upgrade
Debt / Equity Ratio	0.01	0.01	0.27	0.26	0.19	0.00	Upgrade
Asset Turnover	0	0	0.00	0.00	0.00	0	Upgrade
Quick Ratio	3.09	3.09	2.07	5.55	18.43	13.38	Upgrade
Current Ratio	3.14	3.14	2.16	5.92	18.95	13.51	Upgrade
Return on Equity (ROE)	-119.83%	-119.83%	-61.09%	-38.91%	-51.00%	-38.80%	Upgrade
Return on Assets (ROA)	-55.19%	-55.19%	-26.78%	-17.85%	-25.92%	-23.47%	Upgrade
Return on Capital (ROIC)	-65.75%	-65.75%	-29.98%	-18.98%	-27.12%	-24.38%	Upgrade
Earnings Yield	-24.05%	-40.64%	-14.79%	-23.99%	-16.67%	-5.22%	Upgrade
Buyback Yield / Dilution	-10.92%	-10.92%	-0.30%	-11.14%	-34.55%	-16.70%	Upgrade

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q